{"id":1283863,"title":"DSEN Abstract: Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-05","captureTimestamp":"2026-02-05T21:06:00.300000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52735.html","snippet":"DSEN Abstract Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada In 2019, some batches of ranitidine, a readily available histamine H-2 receptor antagonist that counteracts stomach acid, contained an impurity called N-nitrosodimethylamine…","rawSnapshotUrl":"/api/snapshots/raw/1283863","browseUrl":"https://replay.healtharchive.ca/job-8/20260205210600/https://cihr-irsc.gc.ca/e/52735.html#ha_snapshot=1283863","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}